ORIGINAL
Eficacia de los análogos de somatostatina radiomarcados (90Y-DOTATOC y 177Lu-DOTATATE) en pacientes con tumores neuroendocrinos metastásicos, experiencia de centro único en México
Effectiveness of radiolabelled somatostatin analogues (90Y-DOTATOC and 177Lu-DOTATATE) in patients with metastatic neuroendocrine tumours: a single centre experience in Mexico
Leído
480
Vecesse ha leído el artículo
176
Total PDF
304
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 1 | 1 | 0 | 1 |
| 2023 10 | 1 | 0 | 1 |
| 2023 5 | 12 | 0 | 12 |
| 2023 3 | 9 | 2 | 11 |
| 2022 5 | 8 | 2 | 10 |
| 2022 3 | 2 | 0 | 2 |
| 2021 8 | 1 | 0 | 1 |
| 2021 7 | 2 | 2 | 4 |
| 2021 4 | 6 | 12 | 18 |
| 2021 3 | 2 | 2 | 4 |
| 2021 2 | 4 | 4 | 8 |
| 2020 1 | 1 | 2 | 3 |
| 2020 12 | 2 | 2 | 4 |
| 2020 9 | 0 | 1 | 1 |
| 2020 2 | 5 | 4 | 9 |
| 2020 1 | 4 | 4 | 8 |
| 2019 10 | 3 | 2 | 5 |
| 2019 3 | 3 | 4 | 7 |
| 2019 2 | 14 | 0 | 14 |
| 2019 1 | 95 | 76 | 171 |
| 2018 12 | 27 | 20 | 47 |
| 2018 11 | 18 | 14 | 32 |
| 2018 10 | 12 | 10 | 22 |
| 2018 9 | 14 | 4 | 18 |
| 2018 8 | 6 | 1 | 7 |
| 2018 7 | 13 | 2 | 15 |
| 2018 6 | 11 | 0 | 11 |
| 2018 5 | 7 | 0 | 7 |
| 2018 3 | 2 | 0 | 2 |
| 2018 2 | 1 | 0 | 1 |
| 2018 1 | 1 | 0 | 1 |
| 2017 9 | 0 | 1 | 1 |
| 2017 8 | 1 | 0 | 1 |
| 2017 7 | 1 | 0 | 1 |
| 2017 6 | 3 | 1 | 4 |
| 2017 5 | 9 | 2 | 11 |
| 2017 4 | 3 | 1 | 4 |
| 2016 1 | 0 | 1 | 1 |
Mostrar todo
